RYR2 and catecholaminergic polymorphic ventricular tachycardia: Indeed, a recent report demonstrates that the oxidation of RyR2 can contribute to the development of Ca2+ waves in CPVT, which can be prevented by antioxidant treatment (Hamilton et al., 2020).